Genmab A/S ADR (NQ: GMAB )
Price and Volume
Detailed QuoteVolume | 337,146 |
Open | 37.66 |
Bid (Size) | 37.60 (1) |
Ask (Size) | 38.81 (1) |
Prev. Close | 37.56 |
Today's Range | 37.58 - 37.89 |
52wk Range | 26.19 - 47.50 |
Shares Outstanding | N/A |
Dividend Yield | N/A |
Top News
More News
This Foreboding Sign Looms Over Genmab's Chart
March 31, 2023
What 4 Analyst Ratings Have To Say About Genmab
March 01, 2023
Performance
More News
Read More
Earnings Outlook For Genmab
February 21, 2023
Alkermes Stock Sees Rising Relative Price Strength
February 17, 2023
Moderna Stock Getting Closer To Key Technical Benchmark
February 10, 2023
Anavex Life Sciences Stock Shows Improved Price Strength Rating
February 07, 2023
Incyte Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
January 19, 2023
Vertex Pharmaceuticals Stock Sees Rising Relative Strength
January 11, 2023
3 Biotech Companies to Watch in 2023
January 06, 2023
Moderna Stock Shows Surprising Strength; Key Rating Upgraded
December 14, 2022
Our 7 Top Biotech Stock Picks for 2023
December 09, 2022
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating
December 08, 2022
3 Hot Stocks That Could Live Up to Their Lofty Valuations
December 08, 2022
Is AbbVie Stock a Buy Now?
December 06, 2022
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
November 29, 2022
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84
November 11, 2022
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
3 Hail Mary Plays to Bring Your Stock Portfolio Back From the Brink
October 25, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.